Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
NYSE
Novo Nordisk AS, up 95 cents to $43.67
U.S. regulators approved the pharmaceutical company's diabetes drug to be used to treat obesity, the first injectable cleared for weight loss.
Walgreen Co., up 16 cents to $76.67
Wall Street is ecstatic over the numbers from the drug store's latest quarter, with many analysts upping their price targets on the stock.
Brookfield Residential Properties Inc., up $1.15 to $24.01
Brookfield Asset Management is buying the slice of the land developer it does not own after upping its offer by more than 5 per cent.
Transocean Ltd., down 37 cents to $18.77
Crude prices that stabilized this week after months of declines slumped again and dragged big energy companies down with them.
Nasdaq
Taser International Inc., 85 cents to $26.87
Major orders continue to roll in for the maker of defence equipment used by police departments, particularly its body cameras.
GoPro Inc., up $4.87 to $66.41
Wall Street has been down on the adventure camera maker but Wedbush says consumers love it and major retailers are selling out.
Virgin America Inc., up $5.19 to $41
Analysts have tried to single out which airlines will win big with oil prices dropping, and Virgin is the latest favourite.
Adamas Pharmaceuticals Inc., $1.45 to $16.10
A new application for Namzaric from the drugmaker and partner Actavis was approved by the FDA for Alzheimer's-type dementia.
This content appears as provided to The Globe by the originating wire service. It has not been edited by Globe staff.